7Baggers
 Anavex Life Sciences Faces Severe Stock Drop After EU Regulatory Setback  timothysykes.com Mon, 17 Nov 2025 12:02:32 GMT
 Anavex Life Sciences Faces Share Decline Amid European Regulatory Setback  timothysykes.com Sat, 15 Nov 2025 13:20:00 GMT
 anavex faces setback as chmp issues negative trend vote on alzheimer’s drug  Investing.com Nigeria Sat, 15 Nov 2025 00:25:50 GMT
 JonesTrading Maintains Anavex Life Sciences(AVXL.US) With Hold Rating  富途牛牛 Fri, 14 Nov 2025 18:31:00 GMT
 12 Health Care Stocks Moving In Friday's Intraday Session  Benzinga Fri, 14 Nov 2025 17:06:24 GMT
 AVXL’s Roller-Coaster Ride: Time to Buy?  StocksToTrade Fri, 14 Nov 2025 15:04:00 GMT
 Recent Developments  timothysykes.com Fri, 14 Nov 2025 14:19:00 GMT
 Anavex (AVXL) Shares Plunge After EU Setback for Alzheimer's Dru  GuruFocus Fri, 14 Nov 2025 14:00:20 GMT
 Anavex (AVXL) Faces Regulatory Challenges for Alzheimer's Drug i  GuruFocus Fri, 14 Nov 2025 13:50:19 GMT
 anavex faces setback as chmp issues negative trend vote on alzheimer’s drug  Investing.com Canada Fri, 14 Nov 2025 13:38:47 GMT
 Why Is Anavex Life Sciences Stock (AVXL) Down Today?  TipRanks Fri, 14 Nov 2025 13:28:11 GMT
 Anavex down as Alzheimer’s drug faces EU setback (AVXL:NASDAQ)  Seeking Alpha Fri, 14 Nov 2025 13:06:07 GMT
 Anavex Faces CHMP Setback for Alzheimer’s Drug  TipRanks Fri, 14 Nov 2025 13:02:40 GMT
 Anavex stock plummets after negative CHMP vote on Alzheimer’s drug  Investing.com Fri, 14 Nov 2025 12:55:27 GMT
 Anavex Life Sciences Provides Regulatory Update on Blarcamesine  TradingView Fri, 14 Nov 2025 12:45:01 GMT
 Anavex drops 11% as Martin Shkreli says the pharma is his next short  Seeking Alpha Thu, 13 Nov 2025 18:01:53 GMT
 Novel Alzheimer’s Drug Blarcamesine Scheduled For High-Stakes EMA Oral Explanation  Citeline News & Insights Wed, 12 Nov 2025 14:31:38 GMT
 anavex investors await critical regulatory decision  AD HOC NEWS Tue, 11 Nov 2025 06:06:04 GMT
 price-driven insight from (avxl) for rule-based strategy  news.stocktradersdaily.com Tue, 11 Nov 2025 01:52:03 GMT
 Anavex dips amid oral hearing scheduled for lead drug in EU  Seeking Alpha Mon, 10 Nov 2025 18:37:22 GMT
 anavex investors brace for high-stakes regulatory decision  AD HOC NEWS Thu, 06 Nov 2025 07:24:04 GMT
 published on: 2025-11-03 08:48:57  newser.com Mon, 03 Nov 2025 14:48:57 GMT

Anavex Life Sciences Corp
(NASDAQ:AVXL) 

AVXL stock logo

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Pha...

Founded: 2004
Full Time Employees: 16
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends